1. Home
  2. Labeler Index
  3. Teva Pharmaceuticals Usa, Inc.
  4. 0093-5352
  5. NDC Package Code: 0093-5352-86 Acamprosate Calcium

NDC Package 0093-5352-86 Acamprosate Calcium

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0093-5352-86
Package Description:
180 TABLET, DELAYED RELEASE in 1 BOTTLE
Product Code:
0093-5352
Proprietary Name:
Acamprosate Calcium
Usage Information:
This medication is used along with counseling and support to help people who are alcohol dependent not drink alcohol. Acamprosate works by restoring the natural balance of chemicals in the brain (neurotransmitters). Before starting this medication, you should no longer be drinking alcohol. Acamprosate has not been shown to work well if you are still drinking alcohol when you start taking it.
11-Digit NDC Billing Format:
00093535286
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
180 EA
Labeler Name:
Teva Pharmaceuticals Usa, Inc.
Sample Package:
No
FDA Application Number:
ANDA200143
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
03-25-2016
End Marketing Date:
03-31-2021
Listing Expiration Date:
03-31-2021
Exclude Flag:
D
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 0093-5352-86?

The NDC Packaged Code 0093-5352-86 is assigned to a package of 180 tablet, delayed release in 1 bottle of Acamprosate Calcium, labeled by Teva Pharmaceuticals Usa, Inc.. The product's dosage form is and is administered via form.

Is NDC 0093-5352 included in the NDC Directory?

No, Acamprosate Calcium with product code 0093-5352 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by Teva Pharmaceuticals Usa, Inc. on March 25, 2016 and its listing in the NDC Directory is set to expire on March 31, 2021 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 0093-5352-86?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 180.

What is the 11-digit format for NDC 0093-5352-86?

The 11-digit format is 00093535286. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
4-4-20093-5352-865-4-200093-5352-86